Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables
Table 1
Comparison of the general status and study data between diabetes groups and control group.
C
D1
D2
D3
Number
86
112
93
56
Age (years)
55.2 ± 12.4
54.9 ± 13.1
53.7 ± 12.5
62.6 ± 11.4
BMI (Kg/m2)
26.5 ± 3.1
26.3 ± 3.7
26.2 ± 2.9
26.8 ± 3.7
Course (year)
8.9 ± 1.3
9.9 ± 1.7
11.8 ± 2.4
SBP (mmHg)
111.3 ± 10.3
124.0 ± 14.3b
130.9 ± 16.9b
135.5 ± 17.3b
DBP (mmHg)
71.4 ± 8.3
77.8 ± 6.5b
82.7 ± 7.8b
86.1 ± 14.5b
SCr (mol/L)
63.62 ± 8.79
64.96 ± 15.27
69.02 ± 20.32
78.49 ± 24.12
BUN (mmol/L)
4.09 ± 1.01
6.12 ± 1.31
6.41 ± 1.37
6.76 ± 1.70
HbA1c (%)
7.80 ± 3.28
8.89 ± 2.59
9.97 ± 2.91c
TG (mmol/L)
1.69 ± 1.01
1.71 ± 0.97
1.99 ± 1.03
2.13 ± 1.16
TC (mmol/L)
4.33 ± 0.77
5.07 ± 0.83b
5.36 ± 1.35b
6.40 ± 1.76b
LDL-C (mmol/L)
1.92 ± 0.33
3.02 ± 0.67b
2.80 ± 1.23a
3.97 ± 1.31bcf
HDL-C (mmol/L)
1.15 ± 0.12
1.17 ± 0.22
1.13 ± 0.31
1.17 ± 0.30
Hs-CRP (mmol/L)
1.03 ± 0.94
2.41 ± 1.07a
3.95 ± 1.18bd
4.51 ± 1.89bdf
TNF-α (mg/mL)
1.01 ± 0.45
1.99 ± 0.56a
2.73 ± 0.72bd
4.10 ± 0.95bdf
UMCP-1/Ucr (ng/mg)
4.51 ± 2.29
24.70 ± 5.37a
70.59 ± 18.93bd
122.85 ± 63.76bdf
SAA (ug/L)
163.90 ± 37.13
318.31 ± 34.35a
490.13 ± 37.24bd
665.04 ± 64.13bdf
Ln (UAE/Ucr)*
2.19 ± 0.60
2.37 ± 0.86a
4.08 ± 0.58bd
7.34 ± 0.90bdf
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; BUN: blood urea nitrogen; SCr: serum creatinine; HbA1c: glycohemoglobin A1c; TG: triglyceride; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; hs-CRP: high sensitivity C-reactive protein; TNF-α: tumor necrosis factor alpha; uMCP-1: urinary monocyte chemoattractant protein-1; SAA: serum amyloid-A; UAE/Ucr: urine albumin excretion/urinary creatinine. , diabetic patients versus control; , D2 and D3 versus D1; , D3 versus D2.
*Since the figures of UAE/Ucr were not normally distributed, they were transitioned with ln here (similarly hereinafter).